Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial to Compare the Injection Site Pain Experience of 0.25 mg Semaglutide sc Administered by 2 Different Products

NCT04007107 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT04007107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04007107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial to Compare the Injection Site Pain Experience of 0.25 mg Semaglutide sc Administered by 2 Different Products
Lead sponsor
Novo Nordisk A/S
Phase
Phase 2
Overall status
Completed
Start date
June 27, 2019
Completion date
September 4, 2019
Enrollment
103 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers diabetes mellitus, type 2, healthy volunteers obesity, healthy volunteers overweight